Top Markets
#1 EXOD EXOD +56.80%
#2 CoW Protocol CoW Protocol +38.35%
#3 Glidr Glidr +36.87%
#4 Humanity Humanity +28.61%
#5 Collector Crypt Collector Crypt +19.82%
#6 Walrus Walrus +18.37%
#7 Codatta Codatta +18.00%
#8 Provenance Blockchain Provenance Blockchain +16.83%
#9 Enso Enso +15.35%
#10 The Black Bull The Black Bull +14.70%
Coin of the day
EXOD EXOD
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
MYND Life Sciences Inc. MYND Life Sciences Inc.

MYND Life Sciences Inc.

MYND
Clasificación en acciones #36741
Headquartered in Kelowna, Canada, MYND Life Sciences Inc. operates as a... Headquartered in Kelowna, Canada, MYND Life Sciences Inc. operates as a neuro-pharmaceutical enterprise focused on creating innovative therapies for depressive disorders. The company conducts scientific research and clinical trials across Canada and the United States to develop drugs derived from neuro-anti-inflammatory compounds. A significant part of their work involves the study and development of psilocin and psilocybin extracts, as well as their synthetic analogs.
Precio por acción
$0.05032369
Última sincronización: 2025-05-20
Capitalización bursátil
$2.37M
Cambio (1 día)
0.44%
Cambio (1 año)
0.00%
País
CA
Comercio MYND Life Sciences Inc. (MYND)

Categoría

Healthcare
Ganancias de MYND Life Sciences Inc. (MYND)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di MYND Life Sciences Inc., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de MYND Life Sciences Inc. desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE